COP9 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-55300
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (99%), Rat (99%). Backed by our 100% Guarantee.
Applications
Western Blot, Immunocytochemistry/ Immunofluorescence, Chromatin Immunoprecipitation-exo-Seq
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: LRGIGILKQAIDKMQMNTNQLTSIHADLCQLCLLAKCFKPALPYLDVDMMDICKENGAYDAKHFLCYYYYGGMIYTGLKNFERALYFYEQAITTPAM
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
Novus Biologicals Rabbit COP9 Antibody - BSA Free (NBP2-55300) is a polyclonal antibody validated for use in WB and ICC/IF. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for COP9 Antibody - BSA Free
![Western Blot: COP9 Antibody [NBP2-55300]](https://resources.bio-techne.com/images/products/COP9-Antibody-Western-Blot-NBP2-55300-img0002.jpg "Western Blot: COP9 Antibody [NBP2-55300]")
Western Blot: COP9 Antibody [NBP2-55300]
Western Blot: COP9 Antibody [NBP2-55300] - Western blot analysis in human cell line RT-4.![Immunocytochemistry/ Immunofluorescence: COP9 Antibody [NBP2-55300]](https://resources.bio-techne.com/images/products/COP9-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-55300-img0001.jpg "Immunocytochemistry/ Immunofluorescence: COP9 Antibody [NBP2-55300]")
Immunocytochemistry/ Immunofluorescence: COP9 Antibody [NBP2-55300]
Immunocytochemistry/Immunofluorescence: COP9 Antibody [NBP2-55300] - Staining of human cell line A-431 shows localization to nucleoplasm.![COP9 Antibody - BSA Free Chromatin Immunoprecipitation-exo-Seq: COP9 Antibody - BSA Free [NBP2-55300]](https://resources.bio-techne.com/images/products/nbp2-55300_rabbit-polyclonal-cop9-antibody-25620259103137.jpg "Chromatin Immunoprecipitation-exo-Seq: COP9 Antibody - BSA Free [NBP2-55300]")
Chromatin Immunoprecipitation-exo-Seq: COP9 Antibody - BSA Free [NBP2-55300]
ChIP-Exo-Seq composite graph for Anti-COPS3 (NBP2-55300) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.Applications for COP9 Antibody - BSA Free
Application
Recommended Usage
Chromatin Immunoprecipitation-exo-Seq
1-10ug per reaction
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Western Blot
0.04-0.4 ug/ml
Application Notes
ICC/IF, Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: COP9
Alternate Names
COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis), COP9 signalosome complex subunit 3, CSN3COP9 complex subunit 3, JAB1-containing signalosome subunit 3, SGN3COP9 (constitutive photomorphogenic, Arabidopsis, homolog) subunit 3, Signalosome subunit 3
Gene Symbol
COPS3
Additional COP9 Products
Product Documents for COP9 Antibody - BSA Free
Product Specific Notices for COP9 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...